Discovery and Preclinical Evaluation of a Novel Inhibitor of FABP5, ART26.12, Effective in Oxaliplatin-Induced Peripheral Neuropathy.

Saved in:
Bibliographic Details
Title: Discovery and Preclinical Evaluation of a Novel Inhibitor of FABP5, ART26.12, Effective in Oxaliplatin-Induced Peripheral Neuropathy.
Authors: Warren G; Artelo Biosciences Limited, UK., Osborn M; Artelo Biosciences Limited, UK., Tsantoulas C; Transpharmation Ltd., London, UK., David-Pereira A; Transpharmation Ltd., London, UK., Cohn D; Transpharmation Ltd., London, UK., Duffy P; Apconix Ltd., UK., Ruston L; Seda Pharma Development Services Ltd., UK., Johnson C; Department of Psychological and Brain Sciences, Bloomington, Indiana., Bradshaw H; Department of Psychological and Brain Sciences, Bloomington, Indiana., Kaczocha M; Department of Anesthesiology, Stony Brook University, New York; Institute of Chemical Biology and Drug Discovery, Stony Brook University, New York., Ojima I; Department of Chemistry, Stony Brook University, New York; Institute of Chemical Biology and Drug Discovery, Stony Brook University, New York., Yates A; Artelo Biosciences Limited, UK., O'Sullivan SE; Artelo Biosciences Limited, UK.
Source: The journal of pain [J Pain] 2024 Jul; Vol. 25 (7), pp. 104470. Date of Electronic Publication: 2024 Jan 15.
Publication Type: Journal Article
Journal Info: Publisher: Churchill Livingstone Country of Publication: United States NLM ID: 100898657 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-8447 (Electronic) Linking ISSN: 15265900 NLM ISO Abbreviation: J Pain Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1528-8447
DOI:10.1016/j.jpain.2024.01.335